Analysis of blood markers for early colorectal cancer diagnosis
BackgroundColorectal cancer (CRC) is a very common tumor worldwide. Its mortality can be limited by early diagnosis through screening programs. These programs are based on fecal occult blood testing and colonoscopy. Our objective was to find a model based on the determination of blood biomarkers tha...
Saved in:
Published in | Journal of gastrointestinal oncology Vol. 13; no. 5; pp. 2259 - 2268 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
AME Publishing Company
01.10.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | BackgroundColorectal cancer (CRC) is a very common tumor worldwide. Its mortality can be limited by early diagnosis through screening programs. These programs are based on fecal occult blood testing and colonoscopy. Our objective was to find a model based on the determination of blood biomarkers that was efficacious enough to become part of the early diagnosis of CRC. MethodsIn a total of 221 patients who underwent a colonoscopy, two types of markers were identified (I) classic: carcinoembryonic antigen (CEA), CA19.9, α-fetoprotein, CA125, CA72.4, and ferritin; and (II) experimental: neutrophil gelatinase-associated lipocalin (NGAL), estimated glomerular filtration rate (EGFR), 8-hydroxydeoxyguanosine (8OHdG), calprotectin, and cysteine-rich 61 (Cyr61). We divided the patients into four groups according to colonoscopy results: a control group (n=83) with normal colonoscopy, a polyp group (n=56), a CRC group (n=45), and an inflammatory disease group (n=37). We built an algorithm based on multivariate logistic regression analysis. ResultsA total of 51.6% were males, and the median age was 63 years. We designed an algorithm based on the combination of several markers that discriminated CRC patients from the rest of the patients with a performance of 94%, a sensitivity of 95.6%, and a specificity of 80.6%. Discriminating by sex also resulted in two powerful algorithms, although it performed better in males (97% vs. 91%). ConclusionsOur study has devised a predictive model with high efficacy based on the determination of several biomarkers. We think that it could be incorporated into the set of methods used in CRC screening. |
---|---|
AbstractList | BackgroundColorectal cancer (CRC) is a very common tumor worldwide. Its mortality can be limited by early diagnosis through screening programs. These programs are based on fecal occult blood testing and colonoscopy. Our objective was to find a model based on the determination of blood biomarkers that was efficacious enough to become part of the early diagnosis of CRC. MethodsIn a total of 221 patients who underwent a colonoscopy, two types of markers were identified (I) classic: carcinoembryonic antigen (CEA), CA19.9, α-fetoprotein, CA125, CA72.4, and ferritin; and (II) experimental: neutrophil gelatinase-associated lipocalin (NGAL), estimated glomerular filtration rate (EGFR), 8-hydroxydeoxyguanosine (8OHdG), calprotectin, and cysteine-rich 61 (Cyr61). We divided the patients into four groups according to colonoscopy results: a control group (n=83) with normal colonoscopy, a polyp group (n=56), a CRC group (n=45), and an inflammatory disease group (n=37). We built an algorithm based on multivariate logistic regression analysis. ResultsA total of 51.6% were males, and the median age was 63 years. We designed an algorithm based on the combination of several markers that discriminated CRC patients from the rest of the patients with a performance of 94%, a sensitivity of 95.6%, and a specificity of 80.6%. Discriminating by sex also resulted in two powerful algorithms, although it performed better in males (97% vs. 91%). ConclusionsOur study has devised a predictive model with high efficacy based on the determination of several biomarkers. We think that it could be incorporated into the set of methods used in CRC screening. |
Author | Navarro Roldán, Francisco Bayo Calero, Juan Casado Monge, Pedro Germán Castaño López, Miguel Angel Díaz Portillo, Jacobo Bejarano García, Ana |
Author_xml | – sequence: 1 givenname: Juan surname: Bayo Calero fullname: Bayo Calero, Juan – sequence: 2 givenname: Miguel Angel surname: Castaño López fullname: Castaño López, Miguel Angel – sequence: 3 givenname: Pedro Germán surname: Casado Monge fullname: Casado Monge, Pedro Germán – sequence: 4 givenname: Jacobo surname: Díaz Portillo fullname: Díaz Portillo, Jacobo – sequence: 5 givenname: Ana surname: Bejarano García fullname: Bejarano García, Ana – sequence: 6 givenname: Francisco surname: Navarro Roldán fullname: Navarro Roldán, Francisco |
BookMark | eNpVkE1LAzEQhoNUsNae_AM5CrKaj02yuSil-AUFLwreQprM1q3ppiZbof_eoEVwLvPCvPPM8J6iUR97QOickitGCVfX61WsGK1UrY7QmDGqK6n026hooppKNpqeoGnOa1Kq1oIINka3s96Gfe4yji1ehhg93tj0ASnjNiYMNoU9djHEBG6wATvbO0jYd3bVx7J2ho5bGzJMD32CXu_vXuaP1eL54Wk-W1SOi2aotBDOE8mkr6UXUmgOxLOlsgRs46kVnkvOoVHKclE76mptSa1800LrQQGfoJtf7na33IB30A_JBrNNXXl3b6LtzP9J372bVfwyWkpCGlYAFwdAip87yIPZdNlBCLaHuMuGKa5qKWpKi_Xy1-pSzDlB-3eGEvMTtSlRF2VK1Pwbl0J00g |
CitedBy_id | crossref_primary_10_1007_s10238_023_01260_5 crossref_primary_10_3390_cancers15112984 |
ContentType | Journal Article |
Copyright | 2022 Journal of Gastrointestinal Oncology. All rights reserved. 2022 Journal of Gastrointestinal Oncology. |
Copyright_xml | – notice: 2022 Journal of Gastrointestinal Oncology. All rights reserved. 2022 Journal of Gastrointestinal Oncology. |
DBID | AAYXX CITATION 7X8 5PM |
DOI | 10.21037/jgo-21-747 |
DatabaseName | CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 2219-679X |
EndPage | 2268 |
ExternalDocumentID | 10_21037_jgo_21_747 |
GroupedDBID | 04C AAWTL AAYXX ADBBV ALMA_UNASSIGNED_HOLDINGS BAWUL BMSDO CITATION DIK GX1 HYE M~E OK1 RNS RPM 7X8 5PM |
ID | FETCH-LOGICAL-c358t-955cd0626d46d56593e0d2b7a0ea8d1a5d3633e877a354c1c49a047d8fefde7e3 |
IEDL.DBID | RPM |
ISSN | 2078-6891 |
IngestDate | Fri Sep 01 02:39:38 EDT 2023 Fri Aug 16 21:37:21 EDT 2024 Fri Aug 23 02:53:08 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 5 |
Language | English |
License | Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c358t-955cd0626d46d56593e0d2b7a0ea8d1a5d3633e877a354c1c49a047d8fefde7e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ORCID: 0000-0002-6114-4222. Contributions: (I) Conception and design: J Bayo Calero; (II) Administrative support: J Bayo Calero; (III) Provision of study materials or patients: PG Casado Monge, A Bejarano García; (IV) Collection and assembly of data: MA Castaño López, F Navarro Roldán; (V) Data analysis and interpretation: J Díaz Portillo; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660082/ |
PQID | 2737465411 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9660082 proquest_miscellaneous_2737465411 crossref_primary_10_21037_jgo_21_747 |
PublicationCentury | 2000 |
PublicationDate | 2022-10-00 20221001 |
PublicationDateYYYYMMDD | 2022-10-01 |
PublicationDate_xml | – month: 10 year: 2022 text: 2022-10-00 |
PublicationDecade | 2020 |
PublicationTitle | Journal of gastrointestinal oncology |
PublicationYear | 2022 |
Publisher | AME Publishing Company |
Publisher_xml | – name: AME Publishing Company |
SSID | ssj0000495052 |
Score | 2.2936127 |
Snippet | BackgroundColorectal cancer (CRC) is a very common tumor worldwide. Its mortality can be limited by early diagnosis through screening programs. These programs... |
SourceID | pubmedcentral proquest crossref |
SourceType | Open Access Repository Aggregation Database |
StartPage | 2259 |
SubjectTerms | Original |
Title | Analysis of blood markers for early colorectal cancer diagnosis |
URI | https://search.proquest.com/docview/2737465411 https://pubmed.ncbi.nlm.nih.gov/PMC9660082 |
Volume | 13 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NS8NAEB1aD-JF1CrWL1Yo3tYm2d1schIRtQgVDwq9hf2KVmwqbT34753dNNpevQVClvB2yLzJvnkD0HNaasU4oyJLNOXOCaqVEBSpBOfKlkma-d7h4WM6eOEPIzFqgWh6YYJo3-jxZfUxuazGb0Fb-Tkx_UYn1n8a3nhHSUxd_Ta0MUBXSvT3mvL64Wx-qBymP5pmeVz35SXBzOf9dUqTmEo_T2U1E_3Ry3Vx5Eq2uduB7SVNJNf16-xCy1V70LmusESefJMLEoSb4Y_4HmwOl-fjHbhqPEbItCRBk04mXn8zmxMkp8R5N2Pifar9dw7XN37PZ8TWervxfB9e7m6fbwZ0OSKBGiayBc2FMDbCosTy1CI3y5mLbKKlipzKbKyEZSljLpNSMcFNbHiuIi5tVrrSOunYAWxU08odAnFSs7y0UhpjvGOhVkoooZ3KeamSiHeh18BVfNZOGAVWEAHVAlHFqwJR7cJ5A2WBkeqPH1Tlpl_zAomS9O5tcdwFuYbx73re63r9DoZA8LxebvnRv588hq3Edy4EHd4JbCxmX-4U-cRCn0H7fhSfhSj6Aa3rz2k |
link.rule.ids | 230,315,730,783,787,888,27938,27939,53806,53808 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9wwEB0BlQoXKB8VS6G4EuLm3SS24-SEEAJtC4t6gIpb5K_QBTaL9uMAv75jZwO7vbW3SFasRM_OvInfvAE4clpqxTijIks05c4JqpUQFKkE58qWSZr52uHeddq95T_uxN0SiKYWJoj2je63q6dBu-r_DtrK54HpNDqxzs_emXeUxNDVWYYPuF-jdC5Jf6hJr2_P5tvKYQCkaZbHdWVeEux8Hu6HNImp9B1V5mPRO8FclEfOxZuLDfjVPGktM3lsTye6bV7_MnH851f5BOszBkpO6-FNWHLVFmyfVph9D17IMQma0PCzfQs-9mZH79tw0tiXkGFJgtydDLy0ZzQmyHuJ80bJxFtg-08ozm_8choRW0v5-uMduL04vznr0ln3BWqYyCY0F8LYCPMdy1OLtC9nLrKJlipyKrOxEpaljLlMSsUEN7HhuYq4tFnpSuukY59hpRpWbheIk5rlpZXSGOPNELVSQgntVM5LlUS8BUcNDsVzbbJRYHIS4CoQLrwqEK4WfGswKnAT-JMNVbnhdFwgB5PeGC6OWyAXwHubz9toL44gJMFOewbB3n_feQir3ZveVXH1_fryC6wlvkAiyP32YWUymroDpC0T_TUs0j85a_Bv |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9wwEB0VKiEuQPlQF0rrSoibd5PYjpNThYAVLSziUCTEJfJXYCmbXe3Hgf76jp0N7PbILVISK9GzM2_iN28AjpyWWjHOqMgSTblzgmolBEUqwbmyZZJmvna4d51e3PJfd-JuodVXEO0b3W9Xz4N21X8M2srRwHQanVjnpnfqHSUxdHVGtuyswEdcs1G2kKg_1cTXt2jzreUwCNI0y-O6Oi8Jlj5PD0OaxFT6riqL8eiNZC5LJBdiTncT7punraUmf9qzqW6bv_8ZOb7rdbZgY85EyUl9ySf44Kpt2DmpMAsfvJBjErSh4af7Nqz15lvwO_CjsTEhw5IE2TsZeInPeEKQ_xLnDZOJt8L2n1Ic3_hpNSa2lvT1J7tw2z3_fXpB510YqGEim9JcCGMjzHssTy3Sv5y5yCZaqsipzMZKWJYy5jIpFRPcxIbnKuLSZqUrrZOO7cFqNazcZyBOapaXVkpjjDdF1EoJJbRTOS9VEvEWHDVYFKPabKPAJCVAViBkeFQgZC343uBU4GLwOxyqcsPZpEAuJr1BXBy3QC4B-Dqet9NePoOwBFvtOQz7777zG6zdnHWLq5_Xlwewnvg6iaD6-wKr0_HMHSJ7meqvYZ7-A7yC8u8 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Analysis+of+blood+markers+for+early+colorectal+cancer+diagnosis&rft.jtitle=Journal+of+gastrointestinal+oncology&rft.au=Bayo+Calero%2C+Juan&rft.au=Casta%C3%B1o+L%C3%B3pez%2C+Miguel+Angel&rft.au=Casado+Monge%2C+Pedro+Germ%C3%A1n&rft.au=D%C3%ADaz+Portillo%2C+Jacobo&rft.date=2022-10-01&rft.pub=AME+Publishing+Company&rft.issn=2078-6891&rft.eissn=2219-679X&rft.volume=13&rft.issue=5&rft.spage=2259&rft.epage=2268&rft_id=info:doi/10.21037%2Fjgo-21-747&rft.externalDBID=PMC9660082 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2078-6891&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2078-6891&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2078-6891&client=summon |